Cardlytics (CDLX) Director Scott A. Hill Receives 2,200 RSU Award

What Happened

• Scott A. Hill, a director of Cardlytics, was granted 2,200 restricted stock units (RSUs) on May 20, 2026. The award is reported as a derivative grant (transaction code A) with no cash paid at grant (acquisition price $0).
• Each RSU represents a contingent right to one share of Cardlytics common stock (or cash equivalent at the issuer’s election). The RSUs will vest in full on the one‑year anniversary of the grant provided Hill remains a director.

Key Details

• Transaction date: May 20, 2026; reported in an amended Form 4 filed Aug 24, 2026 to correct the previously reported number of RSUs.
• Price: $0 (award of RSUs, not a cash purchase or sale).
• Shares owned after transaction: Not specified in the amended filing.
• Footnotes of note:
  • F1: RSUs convert to one share each (or cash equivalent).
  • F2: Amendment corrects an earlier Form 4 (filed May 21, 2026) that reported an incorrect RSU count; the RSU numbers reflect a 1-for-10 reverse stock split effective June 5, 2026.
  • F3: Vesting occurs one year from grant if reporting person remains a director.
• Filing status: This is an amended filing to correct the originally reported RSU amount.

Context

• RSU grants are a form of equity compensation and do not represent an immediate purchase or sale; value is realized only if/when RSUs vest and convert to shares (or cash). This grant should be viewed as a compensation award rather than a direct bullish purchase by the insider.
• The amendment corrects the reported share count and accounts for the company’s reverse split; investors should rely on the amended filing for the accurate award amount.